HOME
HELP
FEEDBACK
SUBSCRIPTIONS
ARCHIVE
SEARCH
TABLE OF CONTENTS
Cancer Research
Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention
Molecular Cancer Therapeutics
Molecular Cancer Research
Cancer Prevention Research
Cancer Prevention Journals Portal
Cancer Reviews Online
Annual Meeting Education Book
Meeting Abstracts Online
Cancer Research
67, , , . doi:
© 2009
American Association for Cancer Research
This Article
Abstract
Full Text
Services
Email this article to a friend
Alert me to new issues of the journal
Breast Cancer Expressing the Activated HER2/neu Is Sensitive to Gefitinib
In vitro
and
In vivo
and Acquires Resistance through a Novel Point Mutation in the HER2/neu
Cancer Res Piechocki et al. 67: 6825
Supplementary Data, Piechocki, et al.
Files in this Data Supplement:
Supplementary Methods and Materials
Methods References
Supplementary Table 1
Supplementary Table 2
Supplementary Table 3
Supplementary Table 4
Supplementary Table 5
Supplementary Table 6
Supplementary Table 7
This Article
Abstract
Full Text
Services
Email this article to a friend
Alert me to new issues of the journal
HOME
HELP
FEEDBACK
SUBSCRIPTIONS
ARCHIVE
SEARCH
TABLE OF CONTENTS
Cancer Research
Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention
Molecular Cancer Therapeutics
Molecular Cancer Research
Cancer Prevention Research
Cancer Prevention Journals Portal
Cancer Reviews Online
Annual Meeting Education Book
Meeting Abstracts Online